• Decrease
  • Normal
  • Increase
U.S. Department of Health and Human Services

About FDA

Percentage of regulatory cases referred to OFS that were reviewed within the timeframe given to OFS in the Case Management System (measures time in OFS only) in the month

Dictionary: Timely review of regulatory cases that come from the field is important as it allows FDA to take appropriate regulatory action such as issuance of a warning letter to the regulated industry. This can lead to a timely correction of problems in the industry resulting in a safer food supply.

Information is current as of June 30, 2014.

Fiscal Year - 2012

Skip graphic and jump to text data

TimeTargetPercentage
Oct 2011N/A71
Nov 2011N/A57
Dec 2011N/A90
Jan 2012N/A92
Feb 2012N/A76
Mar 2012N/A90
Apr 2012N/A100
May 2012N/A84
Jun 2012N/A76
Jul 2012N/A74
Aug 2012N/A82
Sep 2012N/A80

FY 2012 Overall: 80%

Total number of regulatory cases referred to OFS that were reviewed within the timeframe given to OFS in the Case Management System (measures time in OFS only) in the month

Fiscal Year - 2012
Skip graphic and jump to text data.

TimeTargetNumber
Oct 2011N/A24
Nov 2011N/A13
Dec 2011N/A37
Jan 2012N/A22
Feb 2012N/A25
Mar 2012N/A26
Apr 2012N/A1
May 2012N/A27
Jun 2012N/A31
Jul 2012N/A17
Aug 2012N/A31
Sep 2012N/A28

FY 2012 Total: 282

Total number of regulatory cases referred to OFS in the month that are due within the month

Fiscal Year - 2012
Skip graphic and jump to text data.

TimeTargetNumber
Oct 2011N/A34
Nov 2011N/A23
Dec 2011N/A41
Jan 2012N/A24
Feb 2012N/A33
Mar 2012N/A29
Apr 2012N/A1
May 2012N/A32
Jun 2012N/A41
Jul 2012N/A23
Aug 2012N/A38
Sep 2012N/A35

FY 2012 Total: 354

Glossary

Note: The data provided on this website is produced on an ongoing basis for performance management purposes and is subject to change due to updates of preliminary estimates, corrections, or other reasons. In addition, FDA may change the type or amount of data provided on this website at any time. Information marked as "Completed" may include measures and/or key projects for which activities are ongoing but no longer tracked as part of FDA-TRACK.